In the subgroup with tissues available for EGFR testing (N = 332), gender, chronic obstructive pulmonary disease (COPD) status, smoking status, pathological subtype, and pathological T stage (pT) were significantly different between EGFRm patients and EGFR wild-type patients (Table 1). This evidence concerns the gene EGFR and chronic obstructive pulmonary disease.